Associate/Full Professor of Medicine

Indiana University, United States

Updated: 6 days ago
Location: Indiana, PENNSYLVANIA
Deadline: ;

Posting Details
Position Details


Title Associate/Full Professor of Medicine
Specific Title Director of the Vera Bradley Foundation Center for Breast Cancer
Appointment Type Tenure Track Faculty
Department IUSM - Medicine - Hematology/Oncology
Campus IU School of Medicine Indianapolis
Position Summary
Indiana University School of Medicine (IUSM) in conjunction with the Indiana University Simon Comprehensive Cancer Center (IUSSCC) is seeking a collaborative and innovative physician-scientist to Direct the Vera Bradley Foundation Center for Breast Cancer Research (https://medicine.iu.edu/research-centers/breast-cancer). The breast cancer research center at IU School of Medicine is named in recognition of the Vera Bradley Foundation for Breast Cancer . Vera Bradley, a company based in Fort Wayne, Indiana, is a leading designer of women’s handbags and accessories. The company’s co-founders, Barbara Baekgaard and Patricia Miller, began raising money for breast cancer research in 1993, shortly after the death of a friend and colleague. The Vera Bradley Foundation has since committed $37.5 million to IU School of Medicine to advance breast cancer research and treatment in Indiana and around the world.
The Vera Bradley Foundation Center for Breast Cancer Research at Indiana University School of Medicine (VBFC) is focused on dramatically improving therapies for some of the most difficult-to-treat types of breast cancer. The VBFC is home to a multi-disciplinary team of more than 30 breast cancer physicians and scientists who are engaged in basic, translational, and clinical research. This position presents a unique opportunity to lead the expanding clinical and research community of the VBFC within an NCI-designated comprehensive cancer center. The IUSCCC is in an exciting growth phase, having increased NCI funding by 47% over the last five years, resulting in Comprehensive designation in 2019. In addition to the IUSCCC’s research strengths, there are ample opportunities for collaboration within the institution including:
  • The Komen Normal Tissue Bank and IUSCC (https://komentissuebank.iu.edu/ ) is the world’s only repository of normal breast tissue, now with over 4,700 samples supporting over 140 research projects worldwide.
  • The Translational Breast Cancer Research Consortium (TBCRC, http://pub.emmes.com/study/bcrc/) is a collaborative group founded in 2005 to conduct innovative and high-impact clinical trials for breast cancer. Collectively, the 19 TBCRC member institutions work together to foster trial development in a collegial environment that enhances cross-institutional collaborations. IUSCC has been among the top three enrolling members for the last two years.
  • The Hoosier Cancer Research Network (HCRN), is home to over 200 clinical investigators nationwide. The HCRN is an independent clinical trials consortia whose primary focus is on Phase II and III clinical trials. IUSCC serves as the main research base.
  • The Big Ten Cancer Research Consortium (BTCRC) consists of 14 cancer centers, representing the largest collection of NCI-designated Cancer Centers of all athletic conferences in the country. The BTCRC focuses on early phase collaborative clinical trials.
  • The Brown Center for Immunotherapy , which houses six GMP rooms and a Clinimacs Prodigy, a Precision Immunology Laboratory Services (PILS) Core with state of the art flow cytometric, CYTOF, and imaging flow cytometry, a mixed use facility including BSL-3 ISO-7 clean rooms for viral vector production and cell manufacturing of allogeneic cell products
  • The NIH/NCRR National Gene Vector Biorepository for the NCRR and the lentiviral production site for the NIH/NHLBI Gene Therapy Resources Program
  • The IU School of Medicine’s Precision Health Initiative is a $120 million investment intended to place us at the cutting edge of personalized medicine, biomedical research and healthcare delivery. Triple negative breast cancer is a major pillar of the PHI, including creation of a richly-annotated cohort and development of novel patient-derived xenografts.
  • The Indiana Collaborative Initiative for Talent Enrichment (INCITE), a $25 million grant from the Lilly Endowment, is a partnership between IU School of Medicine and local, non-academic partners such as the Indiana Biosciences Research Institute, Eli Lilly and Co., Roche, Dow, Cook, BioCrossroads, IU Health and Eskenazi Health to attract top scientists


IUSM is the nation’s largest allopathic medical school with 9 campuses across Indiana. The IUSCCC and the VBFC are located on the school’s main campus in Indianapolis; VBFC researchers are also located at the main IU Campus in Bloomington with robust collaboration with researchers at Purdue University and Notre Dame. The IUSCCC research physicians and scientists include more than 150 members who lead over 300 clinical trials in pediatric and adult cancers. Indiana University Health is our clinical health system with facilities statewide. The successful candidate will lead the multi-disciplinary breast cancer team serving patients throughout the IU Health System.
As the nation’s largest medical school, IUSM is committed to being an institution that not only reflects the diversity of the learners we teach and the patient populations we serve, but also pursues the values of diversity, equity and inclusion that inform academic excellence. We desire candidates who enhance our representational diversity, as well as those whose work contributes to equitable and inclusive learning and working environments for our students, staff, and faculty. IUSM strives to take an anti-racist stance, regularly evaluating and updating its policies, procedures, and practices to confer equitable opportunities for contribution and advancement for all members of our community. We invite individuals who will join us in our mission to advance racial equity to transform health and wellbeing for all throughout the state of Indiana. The IUSM provides concierge and dual career services to assist new faculty with their personal or family’s relocation needs.
Basic Qualifications
Doctorate or Terminal degree is required. Candidates should be physician scientists who are MDs or MD/PhDs eligible for the rank of Associate or Full Professor.
Department Contact for Questions
Sabrina Hetzel -[email protected]
Additional Qualifications
A track record of multidisciplinary leadership, success in extramural funding, scholarship, and teaching is expected.
Special Instructions
Please include: (1) detailed curriculum vitae, (2) the names and addresses of three references, (3) a two page summary of research accomplishments, and (4) a two page summary of future research interests and plans.
Priority Application Review Deadline
Expected Start Date
OAA # IUSM-01808-2023

Similar Positions